- New Zealand
- /
- Medical Equipment
- /
- NZSE:TRU
TruScreen Group Full Year 2024 Earnings: NZ$0.005 loss per share (vs NZ$0.007 loss in FY 2023)
TruScreen Group (NZSE:TRU) Full Year 2024 Results
Key Financial Results
- Revenue: NZ$2.60m (up 25% from FY 2023).
- Net loss: NZ$2.05m (loss narrowed by 15% from FY 2023).
- NZ$0.005 loss per share (improved from NZ$0.007 loss in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
The primary driver behind last 12 months revenue was the China segment contributing a total revenue of NZ$1.65m (63% of total revenue). Notably, cost of sales worth NZ$1.44m amounted to 55% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to NZ$1.46m (45% of total expenses). Explore how TRU's revenue and expenses shape its earnings.
TruScreen Group shares are up 25% from a week ago.
Risk Analysis
It is worth noting though that we have found 4 warning signs for TruScreen Group (2 make us uncomfortable!) that you need to take into consideration.
Valuation is complex, but we're here to simplify it.
Discover if TruScreen Group might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NZSE:TRU
TruScreen Group
Develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, Eastern Europe, the Middle East/North Africa, and internationally.
Flawless balance sheet slight.